Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,609,220
-
Share change
-
+271,869
-
Total reported value
-
$246,706,606
-
Price per share
-
$53.52
-
Number of holders
-
110
-
Value change
-
+$14,069,952
-
Number of buys
-
48
-
Number of sells
-
46
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q3 2019
As of 30 Sep 2019,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,609,220 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., RICE HALL JAMES & ASSOCIATES, LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, AQR CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, STATE STREET CORP, and WELLS FARGO & COMPANY/MN.
This page lists
110
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.